Viktoria von Manstein

Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops

Viktoria von Manstein, Yang Chul, Diane Richter et al. · Current Signal Transduction Therapy · 2014 · 89 citations · Full text

Medicine, Oncology, Pharmacology +17

Expression of the mi<scp>R</scp>‐302/367 cluster in glioblastoma cells suppresses tumorigenic gene expression patterns and abolishes transformation related phenotypes

Chul Min Yang, Tomohiro Chiba, Boris Brill et al. · International Journal of Cancer · 2015 · 38 citations · Full text

Medicine, Cell Biology, Oncology +17

Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein FUBP1 to its DNA target sequence FUSE

Sabrina Khageh Hosseini, Stefanie Kolterer, Marlene Steiner et al. · Biochemical Pharmacology · 2017 · 25 citations · Full text

Medicine, Molecular Biology, Pharmacology +6

Tumor cell resistance against targeted therapeutics: the density of cultured glioma tumor cells enhances Stat3 activity and offers protection against the tyrosine kinase inhibitor canertinib

Viktoria von Manstein, Bernd Groner · MedChemComm · 2016 · 15 citations · Full text

Medicine, Oncology, Pharmacology +16